IndraLab
Statements
Pirinixic acid affects USP40
2
|
Bisphenol A affects USP40
2
|
Vinclozolin affects USP40
1
|
Valproic acid affects USP40
1
|
Tetrachloromethane affects USP40
1
|
Schizandrin B affects USP40
1
|
Phorbol 13-acetate 12-myristate affects USP40
1
|
Pentabromodiphenyl ether affects USP40
1
|
Paracetamol affects USP40
1
|
Leflunomide affects USP40
1
|
Lead diacetate affects USP40
1
|
Indometacin affects USP40
1
|
Hydralazine affects USP40
1
|
Hsa-miR-484 affects USP40
1
|
Hexabromocyclododecane affects USP40
1
|
Glycidamide affects USP40
1
|
Dibutyl phthalate affects USP40
1
|
Dexamethasone affects USP40
1
|
Cyclosporin A affects USP40
1
|
Coumestrol affects USP40
1
|
Calcitriol affects USP40
1
|
Bisphenol F affects USP40
1
|
Aflatoxin B1 affects USP40
1
|
USP40 affects Parkinson Disease
|
1
USP40 affects GMEB
|
1
Phthalic Acids affects USP40
1
|
ManLAM-TLR2 affects USP40
|
1
GMEB affects USP40
|
1
Antirheumatic Agents affects USP40
1
|
4-hydroxyphenyl retinamide affects USP40
1
|
3-isobutyl-1-methyl-7H-xanthine affects USP40
1
|
1-phenylpropan-2-amine affects USP40
1
|
1,3-dinitrobenzene affects USP40
1
|